(Total Views: 115)
Posted On: 10/05/2022 4:15:50 PM
Post# of 27273

$ALDX News Article - Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy https://marketwirenews.com/news-releases/alde...11391.html


My Twitter: WhyteStocks